PCRX Investors Invited to Head Class Action Lawsuit Against Pacira BioSciences Over Alleged Securities Fraud

Investors in Pacira BioSciences, Inc., a New Jersey-based pharmaceutical company, have been granted the opportunity to lead a securities class action lawsuit over allegations of fraudulent activity. The lawsuit surrounds claims that Pacira misrepresented its financial status and the efficacy of certain products, thereby inflating its stocks artificially. The legal challenge roots from assertions that Pacira failed to disclose operational and business setbacks, particularly concerning the effectiveness and market acceptance of EXPAREL, a non-opioid pain management drug that is one of the company’s top products. Allegedly, the company made misleading statements or failed to provide … Read more

Investors Alert: Join Pacira BioSciences Class Action Lawsuit by March 14, 2025 – Legal Representation Available Through The Gross Law Firm for PCRX Shareholders

Investors in Pacira BioSciences, Inc. are facing critical financial concerns following allegations of securities fraud, prompting a class action lawsuit that demands immediate attention. With a deadline of March 14, 2025, for Pacira’s shareholders to contact The Gross Law Firm to discuss their legal options, time is of the essence for those impacted by the company’s recent stock performance issues. Pacira BioSciences, known for its non-opioid pain management drugs, has come under legal scrutiny after accusations surfaced that the company may have misled investors about its business and financial prospects. These allegations suggest that Pacira … Read more

California Residents File Landmark Class Action Against Congress Members Over Military Aid to Israel

Santa Cruz, Calif. — A legal battle is brewing in Northern California as four residents from Santa Cruz County have aligned themselves with a larger class-action lawsuit that accuses several congressional leaders of misusing their budgetary powers. The lawsuit, named Taxpayers Against Genocide, targets representatives including Jimmy Panetta and Senator Alex Padilla for their role in allocating $26.38 billion in military aid to Israel on April 20, 2024. This significant legal challenge questions the moral and legal grounds of U.S. funding towards Israel, particularly during its controversial military operations in Gaza. Among the Santa Cruz … Read more

Reminder for Regeneron Investors: March 10 Deadline Approaches for Joining Class Action Lawsuit

NEW YORK — Rosen Law Firm, a prominent legal entity specializing in investor rights, has issued a reminder to those who acquired securities from Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) during the period from November 2, 2023, to October 30, 2024. Investors are instructed to take note of a crucial upcoming deadline on March 10, 2025, for the appointment of the lead plaintiff in a class-action lawsuit concerning alleged securities fraud. Investors who have purchased shares within this defined window, referred to as the Class Period, can potentially partake in compensation arrangements on a contingency basis. … Read more